Bile acids may reveal testicular cancer secrets

NCT ID NCT07463508

Recruiting now Knowledge-focused Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at bile acid levels in the blood and tumor tissue of 20 men with testicular germ cell cancer. Researchers want to see if these levels can serve as markers to predict how the disease will progress and how well it responds to treatment. The goal is to improve monitoring and personalized care for testicular cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR OF THE TESTIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant testicular germ cell tumor testicular cancer testicular germ cell tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TESTICULAR GERM CELL CANCER

Contacts and locations

Locations

CHU Clermont-Ferrand
RECRUITING

Clermont-Ferrand, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.